Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Durysta for Ocular Surface Inflammation in Glaucoma
NCT07217678Phase 4Recruiting
- Sponsor
- University of Miami
- Start
- Feb 2026
- Primary completion
- Jan 2028
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of bimatoprost in Glaucoma, ocular hypertension, sponsored by University of Miami. Started Feb 2026; status: recruiting.
02
Drugs
bimatoprost
03
Conditions
Glaucomaocular hypertension
Beyond the preview
Go deeper on NCT07217678.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07217678.